|
Scientist
>
Stefan Carle
Stefan Carle
// studied pharmaceutical biotechnology at Biberach University of Applied Sciences How biopharmaceutical drug substances use the nose as a pathway to the brainBehind the doorman’s back - von Johannes Flamm, Stefan Carle, Martina Stützle, Prof. Dr. Katharina Schindowski Zimmermann
According to WHO estimates, over 1 billion people worldwide suffer from disorders of the central nervous system (CNS). Some of the most familiar are Alzheimer’s, Parkinson’s and multiple sclerosis. Although they have long been the focus of research, effective pharmacotherapies are still unavailable for many of these diseases. What is it about CNS disorders that makes it especially difficult to develop drug products that target pathophysiological...
 |
|
Search:
